Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ATRI Atrion	$459.92	$459.06	$274.98 ▼ $503.24	$809.46M	0.69	23,283 shs	N/A
LMNX Luminex	$36.99	$36.90	$20.61 ▼ $41.69	$1.75B	0.56	873,093 shs	N/A
SILK Silk Road Medical	$27.49	$27.31	$6.08 ▼ $27.51	$1.12B	1.53	1.20 million shs	N/A
SWAV Shockwave Medical	$334.75	$332.85	$157.00 ▼ $334.90	$12.57B	0.88	968,088 shs	N/A
TCMD Tactile Systems Technology	$10.35 +2.2%	$10.57	$8.61 ▼ $21.10	$235.51M	0.95	256,830 shs	124,870 shs

Beginner's Guide To Retirement Stocks

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ATRI Atrion	0.00%	0.00%	0.00%	0.00%	+1.20%
LMNX Luminex	0.00%	0.00%	0.00%	0.00%	0.00%
SILK Silk Road Medical	0.00%	0.00%	0.00%	0.00%	+1.81%
SWAV Shockwave Medical	0.00%	0.00%	0.00%	0.00%	0.00%
TCMD Tactile Systems Technology	+2.17%	+1.07%	+0.68%	-21.53%	-9.45%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ATRI Atrion	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
LMNX Luminex	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SILK Silk Road Medical	0.4449 of 5 stars	0.8	0.0	0.0	4.3	0.0	0.0	0.6
SWAV Shockwave Medical	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
TCMD Tactile Systems Technology	3.0004 of 5 stars	3.0	1.0	0.0	0.0	0.6	2.5	3.1

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ATRI Atrion	0.00	N/A	N/A	N/A
LMNX Luminex	0.00	N/A	N/A	N/A
SILK Silk Road Medical	1.50	Reduce	$27.50	0.04% Upside
SWAV Shockwave Medical	0.00	N/A	N/A	N/A
TCMD Tactile Systems Technology	2.00	Hold	$16.00	54.59% Upside

Current Analyst Ratings Breakdown

Latest SWAV, ATRI, TCMD, LMNX, and SILK Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
5/7/2025	TCMD Tactile Systems Technology	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold
5/6/2025	TCMD Tactile Systems Technology	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Overweight ➝ Neutral	$25.00 ➝ $14.00

(Data available from 7/4/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ATRI Atrion	$181.60M	4.46	$19.68 per share	23.37	$138.02 per share	3.33
LMNX Luminex	$417.40M	4.19	$1.12 per share	32.98	$11.13 per share	3.32
SILK Silk Road Medical	$177.13M	6.31	N/A	N/A	$3.88 per share	7.09
SWAV Shockwave Medical	$787.97M	15.95	$4.31 per share	77.61	$20.02 per share	16.72
TCMD Tactile Systems Technology	$292.98M	0.82	$1.11 per share	9.36	$9.03 per share	1.15

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ATRI Atrion	$19.41M	$10.64	43.23	∞	N/A	10.60%	7.75%	7.12%	N/A
LMNX Luminex	$15.17M	$0.32	72.53	30.83	N/A	5.39%	4.66%	2.91%	N/A
SILK Silk Road Medical	-$55.74M	-$1.37	N/A	N/A	N/A	-29.53%	-37.30%	-21.57%	N/A
SWAV Shockwave Medical	$147.28M	$4.28	78.21	54.34	2.43	20.75%	24.79%	11.95%	N/A
TCMD Tactile Systems Technology	$16.96M	$0.66	15.68	12.32	N/A	5.52%	8.41%	6.10%	8/4/2025 (Estimated)

Latest SWAV, ATRI, TCMD, LMNX, and SILK Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
5/5/2025	Q1 2025	TCMD Tactile Systems Technology	-$0.07	-$0.13	-$0.06	-$0.13	$63.48 million	$61.27 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ATRI Atrion	$8.80	1.91%	N/A	82.71%	21 Years
LMNX Luminex	$0.40	1.08%	N/A	125.00%	N/A
SILK Silk Road Medical	N/A	N/A	N/A	N/A	N/A
SWAV Shockwave Medical	N/A	N/A	N/A	N/A	N/A
TCMD Tactile Systems Technology	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ATRI Atrion	N/A	9.18	3.06
LMNX Luminex	0.52	8.37	6.08
SILK Silk Road Medical	0.49	7.63	6.69
SWAV Shockwave Medical	0.97	13.81	12.61
TCMD Tactile Systems Technology	0.11	4.52	3.99

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ATRI Atrion	66.19%
LMNX Luminex	87.76%
SILK Silk Road Medical	N/A
SWAV Shockwave Medical	95.35%
TCMD Tactile Systems Technology	83.43%

Insider Ownership

Company	Insider Ownership
ATRI Atrion	22.82%
LMNX Luminex	6.60%
SILK Silk Road Medical	3.90%
SWAV Shockwave Medical	3.40%
TCMD Tactile Systems Technology	2.50%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ATRI Atrion	720	1.76 million	1.36 million	Not Optionable
LMNX Luminex	1,325	47.31 million	N/A	Optionable
SILK Silk Road Medical	410	40.63 million	37.91 million	Optionable
SWAV Shockwave Medical	1,468	37.54 million	36.27 million	Optionable
TCMD Tactile Systems Technology	1,037	23.25 million	22.67 million	Optionable

SWAV, ATRI, TCMD, LMNX, and SILK Headlines

Recent News About These Companies

TCMD Tactile Systems Technology, Inc. - Seeking Alpha

July 2 at 5:19 PM | seekingalpha.com

Tactile Systems Technology (NASDAQ:TCMD) investors are sitting on a loss of 76% if they invested five years ago

June 23, 2025 | finance.yahoo.com

Two Sigma Investments LP Sells 31,793 Shares of Tactile Systems Technology, Inc. (NASDAQ:TCMD)

June 9, 2025 | marketbeat.com

Bank of America Corp DE Raises Stake in Tactile Systems Technology, Inc. (NASDAQ:TCMD)

June 4, 2025 | marketbeat.com

New Data Demonstrates Significant Clinical and Quality-of-Life Benefits of Flexitouch® Plus in Treating Lymphedema Among Head and Neck Cancer Survivors

June 3, 2025 | globenewswire.com

Tactile Medical to Present at Upcoming Investor Conferences in June

May 20, 2025 | globenewswire.com

Tactile Systems Technology, Inc. (NASDAQ:TCMD) CFO Sells $29,034.74 in Stock

May 15, 2025 | insidertrades.com

Tactile Systems Technology's (NASDAQ:TCMD) Soft Earnings Don't Show The Whole Picture

May 13, 2025 | finance.yahoo.com

Tactile Systems Technology, Inc. (NASDAQ:TCMD) Director Sells $31,911.00 in Stock

May 10, 2025 | insidertrades.com

Piper Sandler Downgrades Tactile Systems Technology (TCMD)

May 8, 2025 | msn.com

Analysts Have Been Trimming Their Tactile Systems Technology, Inc. (NASDAQ:TCMD) Price Target After Its Latest Report

May 7, 2025 | finance.yahoo.com

Why Tactile Systems Technology, Inc.’s (TCMD) Stock Is Down 33.21%

May 6, 2025 | aaii.comA

Tactile Systems stock tumbles after Q1 miss

May 6, 2025 | investing.com

Tactile Systems downgraded to Neutral from Overweight at Piper Sandler

May 6, 2025 | msn.com

Tactile Systems Technology, Inc. (TCMD) Q1 2025 Earnings Call Transcript

May 5, 2025 | seekingalpha.com

With 81% institutional ownership, Tactile Systems Technology, Inc. (NASDAQ:TCMD) is a favorite amongst the big guns

May 5, 2025 | uk.finance.yahoo.com

Tactile Systems Technology (TCMD) Reports Q1 Loss, Lags Revenue Estimates

May 5, 2025 | zacks.com

Tactile Systems Technology, Inc. Reports First Quarter 2025 Financial Results

May 5, 2025 | globenewswire.com

What To Expect From Tactile Systems Technology Inc (TCMD) Q1 2025 Earnings

May 3, 2025 | finance.yahoo.com

Tactile Medical to Release First Quarter of Fiscal Year 2025 Financial Results on May 5, 2025

April 21, 2025 | globenewswire.com

Tactile Systems Technology: Interesting Devices Company, Need More Clarity

April 7, 2025 | seekingalpha.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

SWAV, ATRI, TCMD, LMNX, and SILK Company Descriptions

Atrion NASDAQ:ATRI

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmic applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. Its cardiovascular products comprise Myocardial Protection System that delivers fluids and medications, and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. The company's ophthalmic products consist of a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. It manufactures products for safe needle and scalpel blade containment; inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

Luminex NASDAQ:LMNX

Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. Its products include Luminex 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids; MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; xPONENT, a software suite to simplify laboratory workflow and enhance productivity; and TDAS, an analysis program designed for development and optimization of nucleic acid assays. The company also provides xTAG assays and products to identify the causative agent for respiratory and gastrointestinal infections, as well as IVD kits for cystic fibrosis genotyping and pharmacogenetic assays used to profile genetic mutations related to drug metabolism; ARIES system, a sample to answer real-time PCR platform; SYNCT data management software solutions; and ARIES cassettes that are self-contained assay consumables, such as ARIES HSV 1&2 Assay, ARIES Flu A/B & RSV Assay, ARIES Group B Streptococcus Assay, ARIES Group A Strep Assay, ARIES Bordetella Assay, ARIES Norovirus Assay, ARIES C. difficile Assay, ARIES MRSA Assay, and SARS-CoV-2 Assay. In addition, it offers VERIGENE system, a semi-automated, multiplex, molecular analysis system for the clinical diagnostics market; VERIGENE test cartridges; Amnis FlowSight imaging flow cytometers; Amnis ImageStream Mark II imaging flow cytometers; Amnis CellStream for cell and particle analysis; Guava easyCyte benchtop flow cytometers; Muse cell analyzers; and IDEAS, an image analysis software. Luminex Corporation was founded in 1995 and is based in Austin, Texas.

Silk Road Medical NASDAQ:SILK

Silk Road Medical, Inc operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization (TCAR). Its products comprise ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and establish temporary blood flow reversal; ENROUTE Transcarotid Stent System for transcarotid access; ENHANCE Transcarotid Peripheral Access Kit, which is used to gain initial access to the common carotid artery; ENROUTE 0.014 Guidewire for atraumatic vessel navigation and target lesion crossing for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a transcarotid rapid exchange balloon for the TCAR procedure. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.

Shockwave Medical NASDAQ:SWAV

Shockwave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels. It also provides product for the treatment of coronary artery disease, such as C2 IVL catheter and C2+IVL catheter that are two-emitter catheters for use in IVL system; and Reducer, a device to treat refractory angina. In addition, the company develops COSIRA-II trial; shockwave C2 Aero, a coronary IVL catheter; shockwave javelin coronary, a non-balloon-based catheter platform to treat of tight, difficult-to-cross coronary lesions; shockwave L6; shockwave E8 catheter, to target long peripheral artery lesions; shockwave javelin peripheral, a non-balloon-based catheter platform, to treat tight, difficult-to-cross peripheral lesions. Further, it offers shockwave carotid IVL, a purpose-built IVL System to treat calcified carotid artery lesions; and Shockwave Crescendo, a platform developed to treat calcified, stenotic heart valves. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.

Tactile Systems Technology NASDAQ:TCMD

$10.35 +0.22 (+2.17%)

Closing price 07/3/2025 03:34 PM Eastern

Extended Trading

$10.26 -0.09 (-0.87%)

As of 07/3/2025 04:52 PM Eastern

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time